Modified PNA-PCR method: a convenient and accurate method to screen plasma KRAS mutations of cancer patients.
about
KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer.Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.Circulating Cell-Free Tumour DNA in the Management of Cancer.Colorectal cancer patients with low abundance of KRAS mutation may benefit from EGFR antibody therapy.Detection of PIK3CA Mutations in Plasma DNA of Colorectal Cancer Patients by an Ultra-Sensitive PNA-Mediated PCR.
P2860
Modified PNA-PCR method: a convenient and accurate method to screen plasma KRAS mutations of cancer patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Modified PNA-PCR method: a con ...... mutations of cancer patients.
@en
Modified PNA-PCR method: a con ...... mutations of cancer patients.
@nl
type
label
Modified PNA-PCR method: a con ...... mutations of cancer patients.
@en
Modified PNA-PCR method: a con ...... mutations of cancer patients.
@nl
prefLabel
Modified PNA-PCR method: a con ...... mutations of cancer patients.
@en
Modified PNA-PCR method: a con ...... mutations of cancer patients.
@nl
P2093
P2860
P356
P1476
Modified PNA-PCR method: a con ...... mutations of cancer patients.
@en
P2093
Baorui Liu
Guolei Tan
Jianzhong Wu
Jifeng Feng
Shaorong Yu
P2860
P304
P356
10.4161/CBT.19075
P577
2012-03-01T00:00:00Z